Clinica chimica acta; international journal of clinical chemistry
Establishing serum proprotein convertase Subtilisin/Kexin type 9 (PCSK9) reference intervals.
Rosaria Vincenza Giglio, Luisa Agnello, Anna Maria Ciaccio, Fabio Del Ben, Giuseppina Levantino, Francesca Ajello, Elisabetta Scirè, Marcello Ciaccio
Published: 202510.1016/j.cca.2025.120774
Abstract
BACKGROUND AND AIMS: Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a key regulator of lipid metabolism and a therapeutic target in cardiovascular disease. Despite its growing clinical relevance, reference intervals (RIs) for circulating PC…
Preview only. Read the full abstract at the source